RAD51 and cervical cancer: Consistent with these findings, several groups have proposed RAD51 as a therapeutic target in various types of cancer, such as glioblastoma [6], pancreas [19], lung [20], colorectal [21, 22], and others, including cervical cancer [23, 24].